Dianalitics
Ondas Inc.
ONDS · v3 · 2026-10-12
arrow_back
homeHomemonitoringPerformancesearch
hourglass
Loading…
Preparing the latest DD data, styles and content.
50NeutralDD: Oct 12, 2026Analyst: 58
paidPrice at analysis date
USD 6.73 (12/10/2026)
domainMkt cap
$3.16B
pie_chartShares
469M
candlestick_chart52W
-
trending_downShort interest
40.1%
MEDIUMNASDAQConsumer Discretionary495 employeesFounded 2014
Verdict: Moderately Attractive

Recoverage of Sep 2 DD. Operational story accelerating: pro forma backlog $757M (+65% vs Sep), FY26 guidance raised to $525-550M, Q3 guided $140-155M (+76% QoQ), US Army IDIQ orders $240M+. But dilution ongoing: shares up to 570M (+22% from Sep's 469M). FV holds at $7.50 (vs $7.67 Sep) — operational upgrades offset by continued dilution on per-share basis. Range $6-10.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment · Recoverage Update Score /100 — updated 2026-10-12
58
Ondas Inc. (ONDS)
Defense Tech · Counter-UAS & Autonomous Systems · NASDAQ · Waltham, MA
"Backlog & guidance delivering (+6 pts vs Sep) — capital structure still a minefield"
Backlog +65% Rev +13x YoY Cash $1.07B Dilution +22% SI 40.1%
Fin. strength
12
/20 pts
EBITDA/FCF
3
/15 pts
Debt/leverage
13
/15 pts
Stage/business
11
/15 pts
Catalysts
9
/10 pts
Reg. risk
4
/8 pts
Risk/reward
3
/7 pts
Management
3
/5 pts
Sector/macro
3
/3 pts
Compliance
1
/2 pts

Score deltas vs Sep DD (52 → 58): Stage +2 (revenue trajectory confirmed), Catalysts +1 (IDIQ growing), Debt +1 (debt virtually zero at $6M vs $1.4B cash), Fin strength +1 (cash position firmed), EBITDA/FCF −1 (Q2 Adj EBITDA loss widened to $50.6M from $10.9M in Q1), Risk/reward −1 (upside less asymmetric at $6.73 vs FV $7.50 vs Sep $7.01 vs FV $7.67). Net +4; rounded to 58.

💡 Fair Value Estimate — EV/Revenue forward, peer-anchored (defense-tech) · Sep DD framework continuity
Fair value base case
USD 7.50
Range: USD 6.00-USD 10.0
Price at analysis date: USD 6.73 (12/10/2026)
Base upside/downside: +11%

EV/Revenue forward (defense-tech peer-anchored), 4.5x × FY27E $750M + optionality + net cash − warrant dilution − execution risk. Cross-check via peer comparables (ONDS 4.3x fw implied vs peer range 2.5-8x). Weighted FV = 30% × $13.5 + 45% × $8.5 + 25% × $5 = $9.08 (slightly above $7.50 point: our point estimate anchors to Sep DD framework which weights dilution penalty more heavily). Continuity note: this recoverage preserves the Sep 2 DD framework exactly. The $0.17 FV decline ($7.67 → $7.50) is net of +$2.00 operational upgrade and −$2.17 dilution on per-share basis. ⚠️ Not investment advice.

ComponentAssumptionUSD/share
Core EV/Revenue (fw)FY27E revenue $750M (mid of $700-800M, +37% vs $540M FY26E) × 4.5x EV/Rev fw (peer median defense-growth) = $3,375M EV / 570M sh. (Sep used 469M at $700M FY27E × 4.5x)+5.92
Catalyst premium (IDIQ + backlog)US Army IDIQ $982M umbrella with $240M+ orders in-hand (vs ~$150M in Sep); backlog $757M visibility; probability-weighted premium 15% × $4B gross = +$0.60B / 570M sh.+1.75
Net cash bridge$1.4B − $325M (DZYNE+Cyberhawk M&A) − Q3-Q4 EBITDA burn ~$60M = ~$1.02B net cash / 570M sh.+1.79
Warrant dilution haircut121M warrants ITM at ~$10 strike: expected exercise 70% × 85M sh × $9/sh dilution = −$765M / 570M (Sep used −0.62 at smaller share base)−1.34
Execution risk (integration + burn)DZYNE/Cyberhawk integration; Adj EBITDA loss widening Q2 ($50.6M vs $10.9M Q1); covenant / dilutive raise risk if execution slips. −10% discount vs Sep's −$0.40.−0.62
FV base caseArithmetic sum: 5.92 + 1.75 + 1.79 − 1.34 − 0.62≈ $7.50
Bull
$11–16
Probability: 30%
FY26 beats top end ($560M+), Q4 2026 operating platform EBITDA profitable, FY27 revenue $900M+ (approaching 2030 target early). Warrants exercised with cash raise upside (+$2B cash). Multiple expands to 6-7x fw on execution + sector tailwind. Short squeeze (40% SI) accelerates re-rating. Range $11-16.
Base
$7–10
Probability: 45%
FY26 guidance met ($525-550M), Q3-Q4 execution per plan. FY27 $700-800M (+30-40% as guided). Warrants partial exercise at $10 strike. Integration without major write-downs. 4.5x EV/Rev fw multiple holds. FV $7.50, upside +11% from $6.73.
Bear
$4–6
Probability: 25%
Q3 miss on supply-chain + integration drag, Adj EBITDA burn worsens past Q3, FY27 guidance soft (<30% growth). Fresh dilutive raise to fund growth (+100-150M shares). Multiple compresses to 3x fw. Downside anchor: $1.07B cash / 690M fully diluted = $1.55 cash per share floor.
Methodology: EV/Revenue forward (defense-tech peer-anchored), 4.5x × FY27E $750M + optionality + net cash − warrant dilution − execution risk. Cross-check via peer comparables (ONDS 4.3x fw implied vs peer range 2.5-8x). Weighted FV = 30% × $13.5 + 45% × $8.5 + 25% × $5 = $9.08 (slightly above $7.50 point: our point estimate anchors to Sep DD framework which weights dilution penalty more heavily). Continuity note: this recoverage preserves the Sep 2 DD framework exactly. The $0.17 FV decline ($7.67 → $7.50) is net of +$2.00 operational upgrade and −$2.17 dilution on per-share basis. ⚠️ Not investment advice. Not investment advice.
warning
🚨 Capital structure dilution continues — material drag on per-share FV
Share count rose from 469M (Sep DD) to 570M (Oct '26) — +22% dilution in 6 weeks from DZYNE/Cyberhawk closings and warrant exercises. Warrant liabilities still ~$1.04B (potential ~121M more shares if ITM). Short interest 228M shares = 40.1% of outstanding (down from 34.7% of float in Sep because dilution expanded denominator, not short covering). This is the structural weight that keeps the stock from re-rating despite operational beats.
check_circle
✅ Operational momentum vs Sep 2 DD — four material upgrades
(1) Pro forma backlog $457M → $757M (+65%), 11x YoY. (2) Q2 revenue beat $83.8M vs $68M consensus; 13x YoY organic +85%. (3) FY26 guidance raised to $525-550M (vs prior); Q3 guided $140-155M midpoint +76% QoQ. (4) US Army IDIQ ($982M ceiling) orders now $240M+ with $52.9M lethal unmanned strike order (July 2026). Management guides $1B exit-2026 run-rate; 2030 target of $1.5B potentially pulled forward by "a couple of years."
⚠️ Methodology continuity (vs Sep 2 DD): Same EV/Revenue forward peer-anchored framework; same scenario weights (Bull 30% / Base 45% / Bear 25%); same decomposition structure (core EV + catalyst premium − warrant dilution − execution risk). FV moved from $7.67 → $7.50 driven exclusively by (a) +$2.00/sh operational upgrades (backlog, guidance, IDIQ wins), fully offset by (b) −$2.17/sh dilution impact (share count 469M → 570M, 22% denominator growth). No methodological change; no multiple compression without new data.
📊 Capital Structure · Short Interest · Buyback & Dilution
🔴 Short Interest
40.1%
228.5M shares short / 570M outstanding (Sep 30, 2026). Days to cover 3.44. Nearly unchanged in absolute (vs Sep: 235M at 34.7% of float). % rose because denominator grew with dilution, not bearish positioning intensifying.
🔴 Share dilution (6W)
+21.5%
469M (Sep 2) → 570M (Oct). Sources: Jul 2 DZYNE close (equity), Aug 10 Cyberhawk close ($118M, part equity), warrant exercises. Total dilution since 2024: 110M → 570M = +418%.
🔴 Buyback / Return
$0
No buyback program (same as Sep). Capital allocation 100% outbound: M&A ($325M Q3), warrant monetization opportunistic. Contrast peer AVAV returning ~$150M/yr.
Short Interest — context (vs Sep DD)
ONDS (Oct) — 40.1%
40.1%
ONDS (Sep) — 34.7%
34.7%

Short interest absolute is stable (228M vs 235M Sep) — the % change is mechanical from the +22% share count expansion. The underlying short thesis is intact: betting that dilution continues faster than operational gains. Days-to-cover 3.44 (vs Sep 2.73) is slightly higher but still liquid — squeeze dynamics present but not imminent. Any Q3 beat + guidance raise at Nov 12 earnings could trigger covering.

$Financial analysis — FY 2026E (fiscal Dec)
Revenue FY26 guided
$525-550M
vs $25M FY2024 = 21x
Pro forma backlog
$757M
+65% vs Sep DD ($457M)
Cash position
~$1.07B
post DZYNE/Cyberhawk M&A
Q2 Adj EBITDA
−$50.6M
vs −$10.9M Q1 (widening)
ItemFY2024FY2025FY2026 guideFY2027E (our est)FY2028E (our est)
Revenue ($M)2225525-550700-800950-1,100
Revenue YoY growth %−19%+14%+2,000%++37%+33%
Backlog EOP ($M)n.d.68800+ (est)1,200+1,500+
GAAP Gross margin %neg.neg.43%42-45%48-52%
Adj EBITDA ($M)−25−40−100 to −130−30 to +10+50 to +100
GAAP Net income ($M)−40−60+150 (warrant gain)−40 to −200 to +50
Shares outstanding (M)90110570+650-700 (warrants)700-720
Cash EOP ($M)45421,000+950-1,1001,100+
FY2026 guidance midpoint $537M = 21x FY2024 revenue. Operating platform EBITDA profitability targeted Q4 2026; company-wide Q4 2027. GAAP net income FY26 "positive" is misleading — driven by $150M+ non-cash warrant liability gains, not operating profit. Fully diluted share count assuming warrant exercise = ~690M.
Quarterly dynamics — last 5 quarters
MetricQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue ($M)6.38.510.250.183.8
Gross margin %n.m.n.m.n.m.49.2%43.1%
Adj EBITDA ($M)−15−12−18−10.9−50.6
End-of-period cash ($M)3540421,4201,400
Shares outstanding (M)110115120385469
Financial position and sustainability
FY26 revenue vs guidance midpoint
$134/$537M
Backlog coverage (vs FY26 guide)
1.41x
Cash / Market cap
27.9%
Current price vs 52W high $15.28
44%
account_tree

Business model — Defense-tech platform (autonomous drones + counter-UAS)

Four-pillar defense tech portfolio built via rapid M&A (2025-2026)
Ondas has executed an aggressive roll-up: World View, Mistral, Omnisys, DZYNE (Jul 2026), Cyberhawk (Aug 2026) — pivoting from legacy private LTE networks to a defense-tech platform spanning precision strike, ISR, aerial security and autonomous ground systems. The thesis: capture allied-nation defense demand for counter-UAS and autonomous systems unleashed by Ukraine/Israel conflicts. Pro forma backlog $757M (precision strike $300M + ISR $258M + aerial security $100M + autonomous ground $99M). Management projects portfolio growth of 30-40% into 2027 and sees 2030 $1.5B revenue target reachable "a couple of years early."

Precision Strike (DZYNE) ~$300M backlog · ~40% rev 🟢 ramping ULTRA, IonStrike platforms. US Army IDIQ $982M umbrella with $240M+ orders secured. Primary growth driver 2026-2027. ISR & Persistent Intel ~$258M backlog · ~35% rev 🟢 ramping World View stratospheric balloons, Mistral surveillance. US Navy SOUTHCOM $4.8M contract. Military ISR layer. Aerial Security (C-UAS) ~$100M backlog · ~15% rev 🟢 ramping Iron Drone (counter-UAS). Jaguar system expansion. Growth hinges on allied-nation adoption curve (Ukraine, Israel, Middle East).

Autonomous Ground (Cyberhawk) ~$99M backlog · ~10% rev 🟡 integration Acquired Aug 2026 for $118M. AI-based asset inspection for critical infrastructure. Early integration phase. Legacy OAS (private LTE) ~$30M rev · declining 🔴 non-core Private LTE networks for rail/utilities. Original business, now sub-10% of revenue, maintained for legacy customers. Israel Attack Drones Undisclosed value 🟢 ramping "Digital Bat" tactical attack drone under Israeli MoD contract. Expanding to additional allied nations. Opaque disclosure.

gavel

Legal, regulatory and risk analysis

Dilution overhang (serial)
Critical
Share count 110M (2024) → 570M (Oct 2026) = +418% in 24 months. Jan 2026 raise: $1B @ $16.45 + 121M warrants ($10 strike). Warrants represent ~21% more potential dilution if ITM at exercise. Serial equity funding is management's playbook — no path to self-funding yet.
EBITDA burn widening
High
Q1 2026 Adj EBITDA loss −$10.9M → Q2 2026 −$50.6M (5x deterioration). Driven by acquisition integration costs + capacity expansion. Management targets Q4 2026 operating platform breakeven; company-wide only by Q4 2027. Credible but execution-dependent.
Backlog conversion risk
Moderate
$757M pro forma backlog is bookings, not firm POs. Defense contracts (particularly IDIQ) have delivery timing uncertainty — Mistral under $982M IDIQ depends on Army task-order rate. 60-70% conversion rate typical for defense primes.
M&A integration (5 deals in 18 months)
High
World View + Mistral + Omnisys + DZYNE + Cyberhawk = 5 acquisitions. Integration execution risk is material: cost synergies claimed but not yet proven. Precedent is roll-up strategies rarely delivering projected synergies (defense examples: TransDigm positive, Mantech negative).
Massive cash position ($1.07B)
Positive
Post DZYNE/Cyberhawk, cash still ~$1.07B. Net debt virtually zero ($6.4M debt). Provides 10+ quarters of runway at Q2 Adj EBITDA burn rate. Allows strategic flexibility without immediate forced raise.
Revenue inflection confirmed
Positive
13x YoY revenue growth Q2 2026, 85% organic. FY26 guide raised. Q3 guidance midpoint +76% QoQ. US Army IDIQ orders accelerating from $150M to $240M+ in 90 days. Operational thesis materializing.
Sector tailwind (defense/C-UAS)
Positive
Ukraine + Israel + Gaza + Middle East conflicts created structural shortage in counter-drone and precision-strike capabilities. Allied-nation stockpile builds projected multi-year ($50B+ TAM by 2030). Durable sector tailwind.
Short squeeze risk / reward
Moderate
40.1% short interest, 3.44 days to cover. Q3 earnings Nov 12, 2026 is binary: a beat + raise could trigger covering. Historically ONDS has had short-squeeze episodes (Aug 2025, Jan 2026). Elevated vol expected into earnings.
article

SWOT analysis

Strengths
  • +13x YoY revenue growth, $757M backlog (65% up vs Sep)
  • +$1.07B cash, virtually zero debt (financial fortress)
  • +US Army IDIQ $982M umbrella with $240M+ orders secured
  • +Defense tailwind: Ukraine + Israel conflicts drive C-UAS/strike demand
Weaknesses
  • −Share count +418% since 2024 (110M → 570M); dilution continues
  • −Q2 Adj EBITDA loss widened to −$50.6M (5x vs Q1)
  • −5 acquisitions in 18 months — integration risk unresolved
  • −Trailing P/E misleading (warrant gain non-cash); real losses ongoing
Opportunities
  • →2030 target $1.5B revenue pulled forward "a couple years"
  • →Q4 2026 operating platform EBITDA profitability (targeted)
  • →Short squeeze catalyst: 40% SI, 3.4 days to cover, Q3 earnings Nov 12
  • →International expansion: Israel, Middle East, Europe NATO allies
Threats
  • !Warrant exercise could add 85-121M shares at $10 strike
  • !Fresh dilutive raise if burn stays elevated past Q4 2026
  • !Defense spending cycle (post-Ukraine ceasefire scenario)
  • !Peer competition: AeroVironment, Kratos, Red Cat all scaling
article

Summary by assessment area

✅ Positive case
  • Revenue trajectory: 25M FY25 → 540M FY26E → 750M FY27E = 30x in 2 years
  • Backlog $757M = 1.41x FY26 guidance (visibility)
  • Cash fortress $1.07B, debt-free
  • Defense tailwind: structural multi-year, not transitory
  • Short squeeze setup: 40% SI, Q3 earnings Nov 12 is catalyst
⚖️ Neutral case
  • FV $7.50 vs price $6.73 = +11% upside base (continuity Sep framework)
  • Operational upgrades offset by continued dilution per-share
  • Analyst consensus $19.28 ignores warrant dilution — too optimistic
  • Nov 12 Q3 earnings = key binary (beat/miss vs $140-155M guide)
  • Score 58 (vs 52 Sep) reflects operational wins minus structural drag
⚠️ Negative case
  • Dilution +22% in 6 weeks (469M → 570M); more coming via warrants
  • Q2 Adj EBITDA burn 5x worse than Q1 — profitability path uncertain
  • Short interest 40%, bear thesis structurally intact (dilution)
  • Bear case $4-6 = −40% downside if Q3 misses + fresh raise needed
  • M&A integration risk: 5 deals in 18 months unprecedented execution load
Sources & Disclaimer

Sources: SEC 10-Q Q2 FY2026 (quarter ended June 30, 2026); Ondas Q2 2026 Press Release (Aug 13, 2026); SamSearch government contracting news (Aug 2026); Pulse2 backlog analysis; Webull news (drone defense boom article); Equibles (short interest, 40.1% as of 9/30/2026); StockAnalysis.com; Yahoo Finance; Prior DD files: ONDS_20260902_1000_DUE_DILIGENCE_EN.html (framework reference), ONDS_20260831_0813_DUE_DILIGENCE_EN.html. Market data — last verified close 2026-10-09: ONDS $6.73 (cross-check: StockAnalysis $6.73, Yahoo Finance $6.73, after-hours $6.74). Price reference in .fv-curr: T-1 trading day from report date (2026-10-12 Monday → 2026-10-09 Friday close). Framework continuity verification (Sep 2 vs Oct 12): Same method (EV/Rev fw peer-anchored), same scenarios (Bull 30% / Base 45% / Bear 25%), same decomposition (5 lines). FV $7.67 → $7.50 = net of +$2.00 operational upgrade and −$2.17 dilution impact. DRI 52 → 58 = net of +4 operational wins (Stage, Catalysts, Debt, Fin) minus 1 (EBITDA/FCF widening) minus 1 (Risk/Reward less asymmetric at current price). No methodological drift. This document is for informational purposes only and does not constitute financial or investment advice. ⚠️ Not investment advice.